According to Smith & Nephew 's latest financial reports the company's current revenue (TTM) is $4.61 B. In 2013 the company made a revenue of $4.35 B an increase over the years 2012 revenue that were of $4.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2014 (TTM) | $4.61 B | 6.11% |
2013 | $4.35 B | 5.17% |
2012 | $4.13 B | -3.11% |
2011 | $4.27 B | 7.77% |
2010 | $3.96 B | 5.04% |
2009 | $3.77 B | -0.76% |
2008 | $3.80 B | 12.82% |
2007 | $3.36 B | 21.23% |
2006 | $2.77 B | |
2004 | $2.40 B | 14.21% |
2003 | $2.10 B | 26.21% |
2002 | $1.66 B | 12.49% |
2001 | $1.48 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $94.88 B | 1,955.01% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | $12.16 B | 163.42% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | $5.35 B | 16.03% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $17.43 B | 277.52% | ๐บ๐ธ USA |
![]() Orthofix Medical
OFIX | $0.46 B | -89.92% | ๐บ๐ธ USA |
![]() CONMED CNMD | $1.02 B | -77.90% | ๐บ๐ธ USA |